Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis
Open accessThe DOI matches its Crossref record; 312 of the 326 references it cites were found in a registry or an index; 153 of the 280 sources its claims cite were checked for support.
Abstract
Drug delivery to solid tumors is challenged by multiple physiological barriers arising from the tumor microenvironment, including dense extracellular matrix, cellular heterogeneity, hypoxic gradients, and elevated interstitial fluid pressure. These features hinder the uniform distribution and accumulation of therapeutics, reducing treatment efficacy. Despite their widespread use, conventional two-dimensional monolayer cultures fail to reproduce these complexities, contributing to the poor translational predictability of many preclinical candidates. Three-dimensional multicellular tumor spheroids have emerged as more representative in vitro models that capture essential features of tumor architecture, stromal interactions, and microenvironmental resistance mechanisms. Spheroids exhibit spatially organized regions of proliferation, quiescence, and hypoxia, and can incorporate non-tumor cells to mimic tumor–stroma crosstalk. Advances in spheroid analysis now enable detailed evaluation of drug penetration, cellular migration, cytotoxic response, and molecular gradients using techniques such as optical and confocal imaging, large-particle flow cytometry, biochemical viability assays, and microfluidic integration. By combining physiological relevance with analytical accessibility, spheroid models support mechanistic studies of drug transport and efficacy under tumor-like conditions. Their adoption into routine preclinical workflows has the potential to improve translational accuracy while reducing reliance on animal models.
Overview
CoChat Summary
TL;DR
This review argues that 3D multicellular tumor spheroids better capture tumor microenvironment barriers than 2D monolayers and can be analyzed with imaging, flow cytometry, viability assays, and microfluidics. It synthesizes TME biology, spheroid features, and analytical strategies to improve preclinical drug testing.
Key findings
- Spheroids reproduce spatial gradients seen in solid tumors: proliferative outer rim, quiescent intermediate zone, and hypoxic/necrotic core; these gradients typically emerge when spheroids exceed ~500 μm in diameter, core pH ranges between 6.5 and 7.2, and growth plateaus at approximately 600–800 µm.
- Stromal and ECM incorporation increases drug resistance: breast tumor spheroids with higher fibroblast content showed decreased dextran diffusion and diminished doxorubicin cytotoxicity, while pancreatic triple co-cultures of tumor cells, fibroblasts, and endothelial cells demonstrated greater drug resistance than spheroids lacking either stromal component.
- Spheroid gene expression more closely resembles solid tumors than monolayers: in melanoma spheroids, over 100 transcripts were upregulated and approximately 70 downregulated compared with monolayers; a meta-analysis of NCI-60 monolayers versus clinical tumor samples found about 30% of ~7000 genes with altered expression.
- Analytical approaches include brightfield/confocal/electron/SHG microscopy, large-particle flow cytometry, FLIM-BrdU, and microfluidic systems; large-particle flow cytometry tracked fibroblast migration toward the spheroid core by day 5 and endothelial cell clustering near fibroblasts.
Methods
- Narrative review; no systematic search strategy, inclusion criteria, or meta-analysis is described.
- Synthesizes published literature on TME components, limitations of 2D and in vivo models, spheroid biology, and techniques for spheroid analysis.
- No primary experimental data or sample; findings are drawn from cited studies and illustrative examples.
Limitations
- The paper does not state limitations.
- Evident from the review format: no systematic search or quantitative synthesis is reported, so literature coverage and conclusions may be non-exhaustive.
- Evident from the text: many cited findings come from specific cell lines and tumor models, and the review does not systematically assess reproducibility or generalizability across all tumor types.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
92 Valid · 7 Not valid · 43 Not checked · 20 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“cells located in the intermediate zone are often senescent”
§ Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis > 5. Spheroids as a More Physiologically Relevant TME Model > 5.1. Internal Structure of Spheroids
What the sources say
- Not checked — no full text of the sourcecites [101] Benien P. Swami A. 3D tumor models: History, advances and future perspectives Future Oncol. 2014 10 1311 1327 10.2217/fon.13.274 24947267 source
- Disputedcites [184] Mehta G. Hsiao A.Y. Ingram M. Luker G.D. Takayama S. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy J. Control Release 2012 164 192 204 10.1016/j.jconrel.2012.04.045 22613880 PMC3436947 sourceExperimental — accuracy not yet measured
In the Introduction section “Spheroids as appropriate models for drug delivery” (page not available), the paper describes the layer between the necrotic core and proliferating outer rim as quiescent, not senescent. Quiescence and senescence are distinct cellular states; the cited passage does not support substituting one for the other. (LLM, conf=0.83)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [186] Solomon M.A. Lemera J. D’Souza G.G. Development of an in vitro tumor spheroid culture model amenable to high-throughput testing of potential anticancer nanotherapeutics J. Liposome Res. 2016 26 246 260 10.3109/08982104.2015.1105820 26780923 source
- Could not verifycites [187] McIntyre A. Patiar S. Wigfield S. Li J.L. Ledaki I. Turley H. Leek R. Snell C. Gatter K. Sly W.S. Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy Clin. Cancer Res. 2012 18 3100 3111 10.1158/1078-0432.CCR-11-1877 22498007 PMC3367109 sourceExperimental — accuracy not yet measured
The Results section describes hypoxia, proliferation, apoptosis and necrosis in spheroids, but does not identify an intermediate zone or characterize its cells as senescent. Searches for senescence, quiescence and the intermediate zone found no passage addressing the claim; page numbers were not available in our copy. (LLM, conf=0.75)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Together, these components create a tumor microenvironment (TME) that significantly influences drug penetration, retention, and therapeutic response [1,3,4].”
§ Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis > 1. Introduction
What the sources say
- Supportedcites [1] Sriraman S.K. Aryasomayajula B. Torchilin V.P. Barriers to drug delivery in solid tumors Tissue Barriers 2014 2 e29528 10.4161/tisb.29528 25068098 PMC4106925 source
The Tumor Microenvironment section describes how the extracellular matrix and interstitial fluid pressure affect drug penetration, while acidity and hypoxia affect response to anticancer therapies. The Enhanced permeability and retention effect section explains that nanoparticles remain in tumors partly because of poor lymphatic drainage. Together, these passages support the broad claim, particularly for nanoparticle drug delivery. (LLM, conf=0.90)
- Supportedcites [3] Bartelink I.H. Jones E.F. Shahidi-Latham S.K. Lee P.R.E. Zheng Y. Vicini P. van’t Veer L. Wolf D. Iagaru A. Kroetz D.L. Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle Clin. Pharmacol. Ther. 2019 106 148 163 10.1002/cpt.1211 30107040 PMC6617978 source
In “Studying tumor tissue penetration: Illustration and tools” (page unavailable), the paper says that tumor-microenvironment factors largely determine drug penetration and can limit drug distribution. In “Studying target binding at a cellular/molecular level: Illustration and tools” (page unavailable), it describes tumor macrophages and efflux transporters affecting drug accumulation; the penetration section also links immune-cell composition to immunotherapy efficacy. These passages support the broad claim about penetration, retention, and therapeutic response. (LLM, conf=0.88)
- Partly supportedcites [4] Goenka A. Khan F. Verma B. Sinha P. Dmello C.C. Jogalekar M.P. Gangadaran P. Ahn B.C. Tumor microenvironment signaling and therapeutics in cancer progression Cancer Commun. 2023 43 525 561 10.1002/cac2.12416 37005490 PMC10174093 sourceExperimental — accuracy not yet measured
In “TME-based cancer therapy” (page unavailable), the review says poor tumor vasculature protects the tumor core from therapeutics delivered through the bloodstream, supporting an effect on drug penetration. The same section describes microenvironmental factors altering treatment response and ECM-targeted agents localizing treatment in tumors, but it does not establish an effect on drug retention specifically. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Drug delivery to solid tumors is challenged by multiple physiological barriers arising from the tumor microenvironment, including dense extracellular matrix, cellular heterogeneity, hypoxic gradients, and elevated interstitial fluid pressure. These features hinder the uniform distribution and accumulation of therapeutics, reducing treatment efficacy.”
§ Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis > Abstract
What the sources say
- Partly supportedcites [1] Sriraman S.K. Aryasomayajula B. Torchilin V.P. Barriers to drug delivery in solid tumors Tissue Barriers 2014 2 e29528 10.4161/tisb.29528 25068098 PMC4106925 sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [2] Khan S.U. Fatima K. Aisha S. Malik F. Unveiling the mechanisms and challenges of cancer drug resistance Cell Commun. Signal. 2024 22 109 10.1186/s12964-023-01302-1 38347575 PMC10860306 sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [3] Bartelink I.H. Jones E.F. Shahidi-Latham S.K. Lee P.R.E. Zheng Y. Vicini P. van’t Veer L. Wolf D. Iagaru A. Kroetz D.L. Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle Clin. Pharmacol. Ther. 2019 106 148 163 10.1002/cpt.1211 30107040 PMC6617978 sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Three-dimensional multicellular tumor spheroids have emerged as more representative in vitro models that capture essential features of tumor architecture, stromal interactions, and microenvironmental resistance mechanisms.”
§ Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis > Abstract
What the sources say
- Not checked — no full text of the sourcecites [14] Friedrich J. Seidel C. Ebner R. Kunz-Schughart L.A. Spheroid-based drug screen: Considerations and practical approach Nat. Protoc. 2009 4 309 324 10.1038/nprot.2008.226 19214182 source
- Partly supportedcites [15] Vinci M. Gowan S. Boxall F. Patterson L. Zimmermann M. Court W. Lomas C. Mendiola M. Hardisson D. Eccles S.A. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation BMC Biol. 2012 10 29 10.1186/1741-7007-10-29 22439642 PMC3349530 sourceExperimental — accuracy not yet measured
The Background (page not available) says three-dimensional cultures better reflect tumor architecture and microenvironmental features. The Results (page not available) report that tumor cells were generally less drug-sensitive in three-dimensional culture, but offer reduced drug access and hypoxia-related effects as possible explanations rather than established resistance mechanisms. The Discussion (page not available) describes stromal-cell incorporation as a modification to spheroids, not a feature of spheroids generally. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [16] Hirschhaeuser F. Menne H. Dittfeld C. West J. Mueller-Klieser W. Kunz-Schughart L.A. Multicellular tumor spheroids: An underestimated tool is catching up again J. Biotechnol. 2010 148 3 15 10.1016/j.jbiotec.2010.01.012 20097238 source
- Supportedcites [17] Nath S. Devi G.R. Three-dimensional culture systems in cancer research: Focus on tumor spheroid model Pharmacol. Ther. 2016 163 94 108 10.1016/j.pharmthera.2016.03.013 27063403 PMC4961208 source
Section 2.3 describes MCTS as reproducing tumor-cell characteristics and the layered structure and gradients of tumors. Section 5.5 reports that stromal interactions can alter drug sensitivity and describes resistance mechanisms in spheroids. The paper also notes that spheroids can be made with other cell types, so the claim does not imply every spheroid includes stroma. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Spheroids exhibit spatially organized regions of proliferation, quiescence, and hypoxia, and can incorporate non-tumor cells to mimic tumor–stroma crosstalk.”
- Also stated in: § 5. Spheroids as a More Physiologically Relevant TME Model · plain
“These gradients typically emerge when spheroids exceed ~500 μm in diameter, with proliferative cells localized to the outer rim, quiescent cells residing in intermediate zones, and hypoxic or necrotic cores forming at the center due to limited diffusion [17,184,185].”
§ Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis > Abstract
What the sources say
- Supportedcites [17] Nath S. Devi G.R. Three-dimensional culture systems in cancer research: Focus on tumor spheroid model Pharmacol. Ther. 2016 163 94 108 10.1016/j.pharmthera.2016.03.013 27063403 PMC4961208 source
Section 2.3 describes large spheroids as having oxygen gradients and concentric cell layers: quiescent cells in the middle and highly proliferative cells at the outside. It also identifies oxygen deficiency as a cause of hypoxia. Page numbers are not provided in our copy. (LLM, conf=0.93)
- Supportedcites [184] Mehta G. Hsiao A.Y. Ingram M. Luker G.D. Takayama S. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy J. Control Release 2012 164 192 204 10.1016/j.jconrel.2012.04.045 22613880 PMC3436947 source
The section “Spheroids as appropriate models for drug delivery” describes oxygen and proliferation gradients, with a quiescent layer inside an outer rim of proliferating cells. The section “Challenge 1: Forming and maintaining spheroids of uniform size” also describes a hypoxic core. Page numbers are not provided in our copy. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [185] Groebe K. Mueller-Klieser W. Distributions of oxygen, nutrient, and metabolic waste concentrations in multicellular spheroids and their dependence on spheroid parameters Eur. Biophys. J. 1991 19 169 181 10.1007/BF00196343 2029873 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 5. Spheroids as a More Physiologically Relevant TME Model · plain
86 more claims · 55 with their cited sources checked
Create a free account to see all 162 claims and to verify the 7 references still open.
- It may state two separate claims as one. 63
- Probably not a substantial claim. 12
Citations
Cites
Items 201–312 of 312
Multiphoton fluorescence lifetime imaging of 3D‐stem cell spheroids during differentiation
König, K., Uchugonova, A., & Gorjup, E. (2010) · Microscopy Research and Technique · doi:10.1002/jemt.20866 · Cited by 108
Tumor interstitial fluid pressure as an early-response marker for anticancer therapeutics
Ferretti, S., Allegrini, P. R., Becquet, M. M., & McSheehy, P. M. J. (2009) · Neoplasia · doi:10.1593/neo.09554 · Cited by 106 · cited 1×
“Additionally, increased ECM stiffness and compactness restrict intercellular space, further compromising the efficacy of therapeutic delivery [89,90].”
Groebe, K., & Mueller-Klieser, W. (1991) · European Biophysics Journal · doi:10.1007/bf00196343 · Cited by 104 · cited 1×
“These gradients typically emerge when spheroids exceed ~500 µ m in diameter, with proliferative cells localized to the outer rim, quiescent cells residing in intermediate zones, and hypoxic or necrotic cores forming at the center due to limited diffusion [17,184,185].”
Genetic and Non-Genetic Mechanisms Underlying Cancer Evolution
Shlyakhtina, Y., Moran, K. L., & Portal, M. M. (2021) · Cancers · doi:10.3390/cancers13061380 · Cited by 104 · cited 1×
“By generating a spectrum of phenotypic states, EMT complements clonal evolution and CSC-driven mechanisms to reinforce tumor heterogeneity and therapeutic resistance [136,138].”
Tagliazucchi, G. M., Wiecek, A. J., Withnell, E., & Secrier, M. (2023) · Nature Communications · doi:10.1038/s41467-023-36439-7 · Cited by 104
In vitro 3d cultures to model the tumor microenvironment
Fontana, F., Marzagalli, M., Sommariva, M., Gagliano, N., & Limonta, P. (2021) · Cancers · doi:10.3390/cancers13122970 · Cited by 103 · cited 1×
“Among emerging in vitro models, multicellular tumor spheroids provide a platform that more accurately mimics the architecture, diffusion constraints, and cellular interactions present in solid tumors [112,182,183].”
Chemical approaches to targeting drug resistance in cancer stem cells
Sotiropoulou, P. A., Christodoulou, M. S., Silvani, A., Herold-Mende, C., & Passarella, D. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.05.002 · Cited by 100
Harrison, H., Simões, B. M., Rogerson, L., Howell, S. J., Landberg, G., & Clarke, R. B. (2013) · Breast Cancer Research · doi:10.1186/bcr3396 · Cited by 98 · cited 1×
“In ER α -positive breast cancer, for instance, CSCs may rely on ER α -positive non-CSC populations for paracrine signaling support, reinforcing drug resistance and promoting tumor persistence [128,129].”
Laminin-332-rich tumor microenvironment for tumor invasion in the interface zone of breast cancer
Kim, B. G., An, H. J., Kang, S., Choi, Y. P., Gao, M.-Q., Park, H., & Cho, N. H. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.11.028 · Cited by 98
Drilling for Oil: Tumor-Surrounding Adipocytes Fueling Cancer
Attané, C., & Muller, C. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.03.001 · Cited by 97 · cited 1×
“Thus, adipocytes function not only as structural components of the TME but also as metabolic contributors to tumor progression [60].”
Bartelink, I. H., Jones, E. F., Shahidi‐Latham, S. K., Lee, P. R. E., Zheng, Y., Vicini, P., van ‘t Veer, L., Wolf, D., Iagaru, A., Kroetz, D. L., et al. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1211 · Cited by 96 · cited 2×
“Together, these components create a tumor microenvironment (TME) that significantly influences drug penetration, retention, and therapeutic response [1,3,4].”
Applications of Light-Sheet Microscopy in Microdevices
Albert-Smet, I., Marcos-Vidal, A., Vaquero, J. J., Desco, M., Muñoz‐Barrutia, A., & Ripoll, J. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00001 · Cited by 93 · cited 1×
“These methods have been particularly useful in capturing dynamic biological processes and resolving complex cellular arrangements within intact spheroids [253–255].”
Evaluation of Spheroid 3D Culture Methods to Study a Pancreatic Neuroendocrine Neoplasm Cell Line
Bresciani, G., Hofland, L. J., Dogan, F., Giamas, G., Gagliano, T., & Zatelli, M. C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00682 · Cited by 93 · cited 2×
“For example, extended reagent exposure or parallel quantification using monolayer standards have been implemented to ensure more accurate estimation of viable cell numbers in 3D systems [186,305].”
Cellular plasticity: 1712 to the present day
Tata, P. R., & Rajagopal, J. (2016) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2016.07.005 · Cited by 92 · cited 1×
“Beyond these structural and biochemical limitations, the phenotypic state of cancer cells is also profoundly influenced by their dimensional context [8,9].”
Leite, P. E. C., Pereira, M. R., Harris, G., Pamies, D., dos Santos, L. M. G., Granjeiro, J. M., Hogberg, H. T., Hartung, T., & Smirnova, L. (2019) · Particle and Fibre Toxicology · doi:10.1186/s12989-019-0307-3 · Cited by 92
Chwalek, K., Bray, L. J., & Werner, C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.006 · Cited by 91 · cited 4×
“In vivo, this dormancy is typically overcome through angiogenesis, during which newly formed blood vessels introduce shear forces that sustain endothelial sprouts and support the delivery of therapeutic agents [49,222].”
InfluentialGaspar, V. M., Gonçalves, C., de Melo-Diogo, D., Costa, E. C., Queiroz, J. A., Pichon, C., Sousa, F., & Correia, I. J. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.040 · Cited by 91 · cited 1×
“Several chemotherapeutic agents, such as doxorubicin and epirubicin, exhibit inherent fluorescence, enabling direct visualization of their spatial distribution within spheroids using fluorescence or confocal microscopy [291,292].”
Experimental screening procedures and clinical predictability value.
Goldin, A., Serpick, A. A., & Mantel, N. (1966) · PubMed · Cited by 88
Nanoparticle-based hyperthermia, a local treatment modulating the tumor extracellular matrix
Kolosnjaj-Tabi, J., Marangon, I., Nicolas-Boluda, A., Silva, A. K. A., & Gazeau, F. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.07.010 · Cited by 86
A cationic cholesterol based nanocarrier for the delivery of p53-EGFP-C3 plasmid to cancer cells
Misra, S. K., Naz, S., Kondaiah, P., & Bhattacharya, S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.062 · Cited by 85 · cited 1×
“In cases where pre-labeled cell lines are not available, stable or transient transfection can be employed to introduce fluorescent proteins into specific cell populations prior to spheroid formation [262–264].”
Modelling liver cancer microenvironment using a novel 3D culture system
Hrout, A. A., Cervantes-Gracia, K., Chahwan, R., & Amin, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-11641-7 · Cited by 85 · cited 1×
“Similar behavior has been observed in 3D in vitro systems, where fibroblasts embedded in hydrogel or co-culture matrices exhibit directed migration toward spheroid interiors under hypoxic stress [287].”
Zhang, Q., An, Z.-Y., Jiang, W. G., Jin, W., & He, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115390 · Cited by 85 · cited 1×
“In these settings, increased stiffness not only impedes drug penetration but also fosters an aggressive tumor phenotype and enhances resistance to chemotherapeutic agents [92,98].”
The molecular portrait of in vitro growth by meta-analysis of gene-expression profiles
Sandberg, R., & Ernberg, I. (2005) · Genome Biology · doi:10.1186/gb-2005-6-8-r65 · Cited by 84 · cited 3×
“Gene expression studies comparing monolayer cultures to tumor tissues have demonstrated significant differences [176].”
InfluentialWartenberg, M., Gronczynska, S., Bekhite, M. M., Saric, T., Niedermeier, W., Hescheler, J., & Sauer, H. (2005) · International Journal of Cancer · doi:10.1002/ijc.20596 · Cited by 82
Endothelial YAP/TAZ Signaling in Angiogenesis and Tumor Vasculature
Hooglugt, A., van der Stoel, M. M., Boon, R. A., & Huveneers, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.612802 · Cited by 82 · cited 1×
“These signals modulate gene expression profiles associated with proliferation, EMT, and drug resistance [95,96].”
Xie, Y., Wang, X., Wang, W., Pu, N., & Liu, L. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06422-5 · Cited by 80 · cited 1×
“Through EMT, epithelial cancer cells undergo a dynamic reprogramming process that suppresses epithelial markers, such as E-cadherin, while upregulating mesenchymal markers, like vimentin and N-cadherin [130,131].”
Bauleth-Ramos, T., Feijão, T., Gonçalves, A., Shahbazi, M.-A., Liu, Z., Barrias, C., Oliveira, M. J., Granja, P., Santos, H. A., & Sarmento, B. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.025 · Cited by 79
Presta, M., Tiberio, L., Rusnati, M., Dell’Era, P., & Ragnotti, G. (1991) · Cell Regulation · doi:10.1091/mbc.2.9.719 · Cited by 73 · cited 1×
“This behavior is consistent with the known paracrine interactions in which fibroblasts secrete pro-angiogenic factors such as VEGF and Fibroblast Growth Factor 2 (FGF2), which facilitate endothelial cell growth and organization [283,284].”
Ivanov, D. P., Parker, T. L., Walker, D. A., Alexander, C., Ashford, M. B., Gellert, P. R., & Garnett, M. C. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.01.002 · Cited by 73 · cited 1×
“The most direct approach for monitoring spheroid expansion is brightfield imaging using an optical microscope equipped with a calibrated camera [233,234].”
Adhesion-mediated apoptosis resistance in cancer
Westhoff, M., & Fulda, S. (2009) · Drug Resistance Updates · doi:10.1016/j.drup.2009.08.001 · Cited by 70
Langenbach, F., Berr, K., Naujoks, C. D., Hassel, A., Hentschel, M., Depprich, R. A., Kübler, N. R., Meyer, U., Wiesmann, H., Kögler, G., et al. (2011) · Nature Protocols · doi:10.1038/nprot.2011.394 · Cited by 70 · cited 2×
“Penetration depth can be quantified by imaging serial sections of the spheroid or by generating optical Z-stacks with confocal microscopy [246,247].”
Epigenetic mechanisms of cell adhesion-mediated drug resistance in multiple myeloma
Furukawa, Y., & Kikuchi, J. (2016) · International Journal of Hematology · doi:10.1007/s12185-016-2048-5 · Cited by 69 · cited 1×
“(2) Cell adhesion-mediated resistance, wherein tumor cell interaction with ECM components activates integrin-mediated signaling pathways that promote survival and reduce drug sensitivity [143–145].”
Kim, H., Phung, Y., & Ho, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039556 · Cited by 68 · cited 1×
“A similar trend was observed in hepatocellular carcinoma models, where monolayers showed enrichment in structural gene expression, whereas spheroids upregulated genes related to metabolism and biosynthesis [196–198].”
Cancer Targeted Drug Delivery: An Elusive Dream
(2013) · doi:10.1007/978-1-4614-7876-8 · Cited by 67
Hardt, O., Wild, S., Oerlecke, I., Hofmann, K., Luo, S., Wiencek, Y., Kantelhardt, E., Vess, C., Smith, G. P., Schroth, G. P., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.06.010 · Cited by 64
Szot, C. S., Buchanan, C. F., Freeman, J. W., & Rylander, M. N. (2013) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2012.0684 · Cited by 63 · cited 1×
“Initial studies examining the effects of fluid flow on cellular behavior utilized models in which endothelial cells were seeded into a central channel, flanked by a collagen I matrix containing embedded tumor cells [229].”
Stroma-Rich Co-Culture Multicellular Tumor Spheroids as a Tool for Photoactive Drugs Screening
Yakavets, I., Jenard, S., François, A., Maklygina, Y., Loschenov, V. B., Lassalle, H., Dolivet, G., & Bezdetnaya, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101686 · Cited by 61 · cited 2×
“For instance, in co-culture models containing epithelial and stromal components, fibroblasts have been selectively labeled with membrane-integrating dyes to facilitate post-formation discrimination [266].”
Application of LDH assay for therapeutic efficacy evaluation of ex vivo tumor models
Cox, M. C., Mendes, R., Silva, F., Mendes, T. F., Zelaya-Lazo, A., Halwachs, K., Purkal, J. J., Isidro, I. A., Félix, A., Boghaert, E. R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-97894-0 · Cited by 58 · cited 1×
“Additional markers of cellular integrity, including lactate dehydrogenase release, caspase activation, and changes in mitochondrial membrane potential, have also been adapted to evaluate apoptotic and necrotic responses within 3D tumor models [186,308–310].”
Fibroblasts as Turned Agents in Cancer Progression
Wieder, R. (2023) · Cancers · doi:10.3390/cancers15072014 · Cited by 58
Two-Photon Microscopy Analysis of Gold Nanoparticle Uptake in 3D Cell Spheroids
Rane, T. D., & Armani, A. M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0167548 · Cited by 56 · cited 1×
“The longer excitation wavelengths used in two-photon microscopy also reduce scattering, enabling improved visualization of inner spheroid regions and providing enhanced depth resolution for analyzing drug distribution [297,298].”
Cancer Cell Phenotype Plasticity as a Driver of Immune Escape in Melanoma
Benboubker, V., Boivin, F., Dalle, S., & Caramel, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.873116 · Cited by 56 · cited 2×
“By generating a spectrum of phenotypic states, EMT complements clonal evolution and CSC-driven mechanisms to reinforce tumor heterogeneity and therapeutic resistance [136,138].”
De Simone, U., Roccio, M., Gribaldo, L., Spinillo, A., Caloni, F., & Coccini, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071993 · Cited by 55
Engineering extracellular matrix to improve drug delivery for cancer therapy
He, X., Yang, Y., Li, L., Zhang, P., Guo, H., Liu, N., Yang, X., & Xu, F. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.06.029 · Cited by 54 · cited 1×
“Its dense, cross-linked architecture hinders the diffusion and penetration of therapeutic agents [86].”
Barroso, M., Monaghan, M. G., Niesner, R., & Dmitriev, R. I. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115081 · Cited by 54 · cited 2×
“This approach bypasses intensity-based limitations and eliminates the need for multiple fluorophores, making it particularly suitable for live-cell, high-content imaging of spheroids and organoids [273].”
Quantitative Live-Cell Confocal Imaging of 3D Spheroids in a High-Throughput Format
Leary, E., Rhee, C., Wilks, B. T., & Morgan, J. R. (2018) · SLAS Technology · doi:10.1177/2472630318756058 · Cited by 53 · cited 1×
“The second strategy involves optical sectioning through confocal laser scanning microscopy, which acquires fluorescence from successive focal planes along the Z-axis to generate high-resolution Z-stacks of the spheroid’s internal structure [186,248].”
Horibe, T., Torisawa, A., Akiyoshi, R., Hatta‐Ohashi, Y., Suzuki, H., & Kawakami, K. (2013) · Luminescence · doi:10.1002/bio.2508 · Cited by 52 · cited 1×
“In cases where pre-labeled cell lines are not available, stable or transient transfection can be employed to introduce fluorescent proteins into specific cell populations prior to spheroid formation [262–264].”
Beaumont, K. A., Anfosso, A., Ahmed, F., Weninger, W., & Haass, N. K. (2015) · Journal of Visualized Experiments · doi:10.3791/53486 · Cited by 52 · cited 1×
“Nevertheless, approaches have been developed to infer spatial gradients through differential staining patterns [299].”
Flow-based pipeline for systematic modulation and analysis of 3D tumor microenvironments
Li, C. Y., Wood, D. K., Huang, J. H., & Bhatia, S. N. (2013) · Lab on a Chip · doi:10.1039/c3lc41300d · Cited by 51 · cited 1×
“Large-particle flow cytometry is particularly advantageous, as it permits the analysis of intact spheroids based on physical and optical properties while preserving information about cellular localization and spheroid integrity [276,277].”
Zhang, H., Steed, A., Co, M., & Chen, X. (2021) · Cancer Drug Resistance · doi:10.20517/cdr.2021.32 · Cited by 50 · cited 1×
“This transition imparts enhanced migratory and invasive capacity, survival advantage under stress, and increased resistance to apoptotic stimuli [39,131–133].”
Voissiere, A., Jouberton, E., Maubert, E., Degoul, F., Peyrode, C., Chezal, J.-M., & Miot-Noirault, É. (2017) · PLOS ONE · doi:10.1371/journal.pone.0181340 · Cited by 49 · cited 1×
“Fluorescently labeled antibodies targeting markers such as caspase-3, Ki-67, and hypoxia-inducible factors, or exogenous hypoxia indicators such as pimonidazole and EF5, allow visualization of apoptotic, proliferating, or hypoxic regions, respectively [235,236].”
GLIMELIUS, B., NORLING, B., NEDERMAN, T., & CARLSSON, J. (1988) · Apmis · doi:10.1111/j.1699-0463.1988.tb05327.x · Cited by 48 · cited 1×
“Spheroids also exhibit significantly higher levels of ECM deposition compared to monolayer cultures, particularly when stromal components are present [209,210].”
Analysis of Gene Expression in 3D Spheroids Highlights a Survival Role for ASS1 in Mesothelioma
Barbone, D., Van Dam, L., Follo, C., Jithesh, P. V., Zhang, S.-D., Richards, W. G., Bueno, R., Fennell, D. A., & Broaddus, V. C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150044 · Cited by 48 · cited 1×
“It has been well established that gene expression patterns in spheroids more closely resemble those found in solid tumors than in monolayer cultures [112,193,194].”
Advancements in fluorescence lifetime imaging microscopy Instrumentation: Towards high speed and 3D
Park, J., & Gao, L. (2024) · Current Opinion in Solid State and Materials Science · doi:10.1016/j.cossms.2024.101147 · Cited by 47 · cited 1×
“More recently, fluorescence lifetime imaging microscopy (FLIM) has also emerged as a refined method to assess proliferation in 3D models with improved specificity and reduced signal interference [270,271].”
Cell death and lumen formation in spheroids of MCF-7 cells
Amaral, D. B. J., Urabayashi, S. M., & Machado‐Santelli, M. G. (2010) · Cell Biology International · doi:10.1042/cbi20090024 · Cited by 46
Lee, C.-S., Kim, T., Oh, D., Bae, S., Ryu, J., Kong, H., Jeon, H., Seo, H., Jeon, S., & Kim, T. (2020) · Cancers · doi:10.3390/cancers12030634 · Cited by 46
Reid, B. G., Jerjian, T., Patel, P. R., Zhou, Q., Yoo, B. H., Kabos, P., Sartorius, C. A., & LaBarbera, D. V. (2014) · Current Chemical Genomics · doi:10.2174/2213988501408010027 · Cited by 45 · cited 1×
“Spatial tracking of marker expression—particularly in response to therapeutic agents—can reveal distinct biological responses within proliferative outer zones, hypoxic intermediate layers, or necrotic cores [240–242].”
Self-Renewal and CSCs In Vitro Enrichment: Growth as Floating Spheres
Mehta, P., Novak, C., Raghavan, S., Ward, M., & Mehta, G. (2018) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7401-6_6 · Cited by 43 · cited 1×
“These CSC populations can then be cultured to generate spheroids that retain stem-like properties, including self-renewal and resistance to standard chemotherapeutics [219].”
Jacobi, N., Seeboeck, R., Hofmann, E., Schweiger, H., Smolinska, V., Mohr, T., Boyer, A., Sommergruber, W., Lechner, P., Pichler-Huebschmann, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22475 · Cited by 43 · cited 2×
“These changes can significantly impact how cells respond to therapeutic agents and contribute to discrepancies between in vitro predictions and in vivo outcomes [10].”
Boroujerdi, A., Welser-Alves, J. V., & Milner, R. (2015) · Angiogenesis · doi:10.1007/s10456-015-9464-7 · Cited by 42 · cited 1×
“In addition to its structural and signaling roles, the ECM actively contributes to tumor angiogenesis [83,84].”
Stroma in normal and cancer wound healing
Huet, E., Jaroz, C., Nguyen, H. Q., Belkacemi, Y., de la Taille, A., Stavrinides, V., & Whitaker, H. (2019) · The FEBS Journal · doi:10.1111/febs.14842 · Cited by 42
Vibrational spectroscopic mapping and imaging of tissues and cells
Carter, E. A., Tam, K. K., Armstrong, R. S., & Lay, P. A. (2009) · Biophysical Reviews · doi:10.1007/s12551-009-0012-9 · Cited by 41
Fibrous stroma: Driver and passenger in cancer development
Sharma, V., Letson, J., & Furuta, S. (2022) · Science Signaling · doi:10.1126/scisignal.abg3449 · Cited by 41 · cited 1×
“This mechanosensitive response is particularly significant in desmoplastic tumors, such as pancreatic and breast cancers, where excessive collagen deposition and cross-linking create a dense fibrotic stroma [97].”
Solomon, M. A., Shah, A. A., & D'Souza, G. G. M. (2013) · Mitochondrion · doi:10.1016/j.mito.2012.10.013 · Cited by 39 · cited 1×
“Several chemotherapeutic agents, such as doxorubicin and epirubicin, exhibit inherent fluorescence, enabling direct visualization of their spatial distribution within spheroids using fluorescence or confocal microscopy [291,292].”
Self-citationUse of Fluorescence Lifetime Imaging Microscopy (FLIM) as a Timer of Cell Cycle S Phase
Okkelman, I. A., Dmitriev, R. I., Foley, T., & Papkovsky, D. B. (2016) · PLOS ONE · doi:10.1371/journal.pone.0167385 · Cited by 39 · cited 1×
“A notable application involves quantifying the quenching of Hoechst 33342 fluorescence lifetime upon BrdU incorporation, enabling detection of S-phase cells using a single nuclear dye [270,272].”
Ahmed-Cox, A., Pandžić, E., Johnston, S. T., Heu, C., McGhee, J. B., Mansfeld, F. M., Crampin, E. J., Davis, T. P., Whan, R. M., & Kavallaris, M. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.014 · Cited by 39
Zhang, J. Z., Bryce, N. S., Siegele, R., Carter, E. A., Paterson, D., de Jonge, M. D., Howard, D. L., Ryan, C. G., & Hambley, T. W. (2012) · Integrative Biology · doi:10.1039/c2ib20121f · Cited by 37 · cited 3×
“Beyond these biochemical assays, efforts have been made to employ advanced spectroscopic techniques to capture spatial and compositional changes associated with treatment response [311–313].”
le Roux, L., Volgin, A., Maxwell, D., Ishihara, K., Gelovani, J., & Schellingerhout, D. (2008) · Molecular Imaging · doi:10.2310/7290.2008.00023 · Cited by 37
In vitro 3D Spheroids and Microtissues: ATP-based Cell Viability and Toxicity Assays
Kijańska, M., & Kelm, J. M. (2016) · Europe PMC (PubMed Central) · Cited by 37
Deciphering Cell Intrinsic Properties: A Key Issue for Robust Organoid Production
Picollet-D’hahan, N., Dolega, M. E., Freida, D., Martin, D. K., & Gidrol, X. (2017) · Trends in biotechnology · doi:10.1016/j.tibtech.2017.08.003 · Cited by 36
Progress against cancer (1971–2011): how far have we come?
Tiwari, A. K., & Roy, H. K. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02462.x · Cited by 35 · cited 1×
“Despite widespread use, these models yielded few successful clinical candidates, prompting the NCI to revise its screening strategy [159].”
An, R., Merrill, D., Avramova, L., Sturgis, J., Tsiper, M., Robinson, J. P., Turek, J., & Nolte, D. D. (2014) · SLAS Discovery · doi:10.1177/1087057113516674 · Cited by 35 · cited 1×
“Beyond these biochemical assays, efforts have been made to employ advanced spectroscopic techniques to capture spatial and compositional changes associated with treatment response [311–313].”
Reviewing the Utility of Two Species in General Toxicology Related to Drug Development
Prior, H. M., Baldrick, P., de Haan, L., Downes, N., Jones, K., Mortimer‐Cassen, E., & Kimber, I. (2018) · International Journal of Toxicology · doi:10.1177/1091581818760564 · Cited by 33 · cited 1×
“Regulatory guidelines necessitate testing in both rodent and non-rodent species prior to clinical trials, with murine models favored for their low cost, rapid breeding, and amenability to genetic modification [178,179].”
Evolutionary aspects of cancer resistance
Klein, G. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.01.001 · Cited by 32 · cited 1×
“While stroma in normal tissues may possess anti-tumor properties, tumor-associated stroma—comprising cancer-associated fibroblasts, ECM, endothelial cells, and immune cells—actively facilitates tumor initiation, invasion, and therapeutic resistance [139–142].”
Polymer Thin Film-Induced Tumor Spheroids Acquire Cancer Stem Cell-like Properties
Choi, M., Yu, S. J., Choi, Y., Lee, H. R., Lee, E., Lee, E., Lee, Y., Song, J., Son, J. G., Lee, T. G., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0927 · Cited by 32 · cited 1×
“In addition to acting as a physical barrier, the ECM can bind soluble factors and modulate integrin-mediated signaling, contributing to cell survival, resistance to apoptosis, and altered therapeutic response [212].”
3D Tumor Spheroid Models for In Vitro Therapeutic Screening of Nanoparticles
Daunys, S., Janonienė, A., Januškevičienė, I., Paškevičiūtė, M., & Petrikaitė, V. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-58174-9_11 · Cited by 32 · cited 3×
“Multicellular tumor spheroids are appropriate systems for modeling tumor heterogeneity and microenvironmental complexity [204–206].”
Solomon, M. A., Lemera, J., & D’Souza, G. G. M. (2016) · Journal of Liposome Research · doi:10.3109/08982104.2015.1105820 · Cited by 30 · cited 7×
“For example, extended reagent exposure or parallel quantification using monolayer standards have been implemented to ensure more accurate estimation of viable cell numbers in 3D systems [186,305].”
InfluentialSelf-citationEarly Cancer Detection at the Epithelial Surface
Rogalla, S., & Contag, C. H. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000122 · Cited by 28 · cited 1×
“When genetic labeling is not feasible due to cell-type-specific limitations, an alternative strategy involves pre-labeling cells with membrane-permeable fluorescent dyes prior to aggregation [265,266].”
Ma, Y., Nenkov, M., Chen, Y., & Gaßler, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158352 · Cited by 28 · cited 1×
“Adipocytes constitute a significant stromal component in the TME of several malignancies, including breast, ovarian, and colorectal cancers [57,58].”
Tumor microenvironment and the role of mesenchymal stromal cells
KUCEROVA, L., & SKOLEKOVA, S. (2012) · Neoplasma · doi:10.4149/neo_2013_001 · Cited by 27
Distribution of SiO2 nanoparticles in 3D liver microtissues
Fleddermann, J., Susewind, J., Peuschel, H., Koch, M., Tavernaro, I., & Kraegeloh, A. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s189888 · Cited by 27 · cited 1×
“In parallel, live–dead cell discrimination can be achieved using dyes such as Calcein AM, fluorescein diacetate, or acridine orange to stain viable cells, while ethidium homodimer, ethidium bromide, or propidium iodide are used to identify nonviable populations [112,237].”
Rapid Clearing for High Resolution 3D Imaging of Ex Vivo Pancreatic Cancer Spheroids
Steinberg, E., Orehov, N., Tischenko, K., Schwob, O., Zamir, G. A., Hubert, A., Manevitch, Z., & Benny, O. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207703 · Cited by 27
Evaluation of Nanoparticle Penetration in the Tumor Spheroid Using Two-Photon Microscopy
Pratiwi, F. W., Peng, C., Wu, S., Kuo, C. W., Mou, C., Tung, Y., & Chen, P. (2020) · Biomedicines · doi:10.3390/biomedicines9010010 · Cited by 27 · cited 1×
“The longer excitation wavelengths used in two-photon microscopy also reduce scattering, enabling improved visualization of inner spheroid regions and providing enhanced depth resolution for analyzing drug distribution [297,298].”
Factors to consider when interrogating 3D culture models with plate readers or automated microscopes
Riss, T., & Trask, O. J. (2021) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-020-00537-3 · Cited by 26 · cited 1×
“Nevertheless, both techniques face limitations when imaging spheroids exceeding several hundred micrometers in diameter due to scattering and absorption of excitation and emission light within intact tissue [249].”
(2016) · PubMed · Cited by 25
Complex Tumor Spheroids, a Tissue-Mimicking Tumor Model, for Drug Discovery and Precision Medicine
Kaur, G., Evans, D. M., Teicher, B. A., & Coussens, N. P. (2021) · SLAS DISCOVERY · doi:10.1177/24725552211038362 · Cited by 25 · cited 1×
“The most direct approach for monitoring spheroid expansion is brightfield imaging using an optical microscope equipped with a calibrated camera [233,234].”
Unraveling Adipocytes and Cancer Links: Is There a Role for Senescence?
Wu, Q., Li, B., Sun, S., & Sun, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00282 · Cited by 24 · cited 2×
“Morphological changes include reduced cell size, expanded interstitial spacing, and a pronounced decrease in intracellular lipid content [59].”
Jokela, T. A., & LaBarge, M. A. (2021) · Current Stem Cell Reports · doi:10.1007/s40778-020-00182-2 · Cited by 24 · cited 1×
“The matrix not only supports spheroid assembly but also imposes physical constraints that activate intracellular signaling cascades, including MAPK, PI3K/Akt, and YAP/TAZ pathways [214–216].”
Tumor Models in Cancer Research
Teicher, B. A. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-100-8 · Cited by 23
Processing cellular spheroids for histological examination
Olsen, T. R., Mattix, B., Casco, M., Herbst, A., Williams, C., Tarasidis, A., Evans, G., Jenkins, L. L., McMahan, C. L., Simionescu, D. T., et al. (2014) · Journal of Histotechnology · doi:10.1179/2046023614y.0000000047 · Cited by 22 · cited 1×
“Stains such as hematoxylin and eosin (H&E), toluidine blue, and Masson’s trichrome have been used to evaluate tissue-like organization within spheroids and provide insight into ECM composition [186,243].”
Stem Cell Niche Dynamics: From Homeostasis to Carcinogenesis
Tieu, K. S., Tieu, R. S., Martínez-Agosto, J. A., & Sehl, M. E. (2012) · Stem Cells International · doi:10.1155/2012/367567 · Cited by 22 · cited 1×
“Their survival and resistance characteristics are reinforced by neighboring non-CSC tumor cells that help maintain a specialized microenvironment or “stem cell niche” [126,127].”
Transfection of primary tumor cells and tumor cell lines with plasmid DNA/lipid complexes.
Stopeck, A., Hersh, E. M., Brailey, J. L., et al. (1998) · PubMed · Cited by 21
Gionchiglia, N., Granato, A., Merighi, A., & Lossi, L. (2021) · Biomedicines · doi:10.3390/biomedicines9091166 · Cited by 20
Nuclear envelope proteins, mechanotransduction, and their contribution to breast cancer progression
Henretta, S., & Lammerding, J. (2025) · npj Biological Physics and Mechanics · doi:10.1038/s44341-025-00018-2 · Cited by 19
Bonafè, F., Pazzini, C., Marchionni, S., Guarnieri, C., & Muscari, C. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.28135 · Cited by 18 · cited 1×
“In spheroid-based assays, drug efficacy is often assessed by comparing changes in spheroid size over time relative to untreated controls [301–303].”
Abbasi, M. M., Mehdipour, M., Monfaredan, A., & Jahanban-Esfahlan, R. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.16.6947 · Cited by 17 · cited 1×
“The newly formed vasculature supports continued tumor proliferation by restoring oxygen and nutrient supply and also facilitates metastasis through enhanced intravasation of tumor cells into the circulation [53,54].”
Fabiano, E. D., Poole, J. M., & Reinhart-King, C. A. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00892.2024 · Cited by 17 · cited 1×
“These mechanical cues have been shown to modulate transcriptional programs related to cell adhesion, survival, and drug resistance, leading to gene expression profiles that diverge significantly from those observed in ECM-free conditions [213,217,218].”
Tian, Y. I., Zhang, X., Torrejon, K. Y., Danias, J., Gindina, S., Nayyar, A., Du, Y., & Xie, Y. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.01.033 · Cited by 16 · cited 1×
“These cell lines became the foundation of in vitro screening and continue to be used extensively for evaluating anticancer compounds [160–163].”
Lim, J. J., Vining, K. H., Mooney, D. J., & Blencowe, B. J. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2404146121 · Cited by 16
Visualization of Stem Cell Niche by Fluorescence Lifetime Imaging Microscopy
Okkelman, I. A., Puschhof, J., Papkovsky, D. B., & Dmitriev, R. I. (2020) · Methods in Molecular Biology · doi:10.1007/978-1-0716-0747-3_5 · Cited by 15 · cited 2×
“More recently, fluorescence lifetime imaging microscopy (FLIM) has also emerged as a refined method to assess proliferation in 3D models with improved specificity and reduced signal interference [270,271].”
Muto, J., Imai, T., Ogawa, D., Nishimoto, Y., Okada, Y., Mabuchi, Y., Kawase, T., Iwanami, A., Mischel, P. S., Saya, H., et al. (2012) · PLoS ONE · doi:10.1371/annotation/ab178792-f423-4aaf-8c26-950a54b8fcca · Cited by 15
Warren, B. A., Shubik, P., Wilson, R., Garcia, H., & Feldman, R. (1978) · Cancer Letters · doi:10.1016/s0304-3835(78)93797-7 · Cited by 14 · cited 1×
“They display irregular diameters, lack the hierarchical architecture typical of the arterial-arteriolar-capillary network, and exhibit increased permeability and fragility [55,56].”
Imaging Cellular Spheroids with a Single (Selective) Plane Illumination Microscope
Swoger, J., Pampaloni, F., & Stelzer, E. H. K. (2014) · Cold Spring Harbor Protocols · doi:10.1101/pdb.prot080176 · Cited by 13 · cited 1×
“This results in reduced contrast and loss of spatial resolution, particularly for large spheroids [244].”
PRODH/POX-Dependent Celecoxib-Induced Apoptosis in MCF-7 Breast Cancer
Misiura, M., Ościłowska, I., Bielawska, K., Palka, J. A., & Miltyk, W. (2021) · Pharmaceuticals · doi:10.3390/ph14090874 · Cited by 13
Differentiation States of Phenotypic Transition of Melanoma Cells Are Revealed by 3D Cell Cultures
Fontana, F., Sommariva, M., Anselmi, M., Bianchi, F., Limonta, P., & Gagliano, N. (2024) · Cells · doi:10.3390/cells13020181 · Cited by 11 · cited 1×
“In one comparative study, transcriptomic analysis of melanoma cells cultured as monolayers, monolayers with ECM, and spheroids revealed that gene expression remained largely unchanged between the two monolayer conditions, while spheroid cultures exhibited substantial differences [194,195].”
Multiplexed spatial transcriptomics methods and the application of expansion microscopy
Fortner, A., & Bucur, O. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1378875 · Cited by 10 · cited 1×
“Emerging spatial transcriptomics platforms, such as MERSCOPE (Vizgen), FISSEQ, ExSeq, Slide-seq, and 10x Genomics Visium, now allow for high-resolution, multiplexed mapping of RNA molecules within intact 3D cultures [199–201].”
Time-dependent release of extracellular vesicle subpopulations in tumor CABA I cells
Giusti, I., Francesco, M. D., Cantone, L., D’Ascenzo, S., Bollati, V., Carta, G., & Dolo, V. (2015) · Oncology Reports · doi:10.3892/or.2015.4199 · Cited by 9 · cited 1×
“In other cases, SEM imaging has revealed the presence of extracellular fiber-like structures on the spheroid surface, later confirmed to be collagen, underscoring the technique’s utility in visualizing matrix remodeling and stromal features [258].”
Hoffmann, B., 1 Competence Center Bioinformatics, I. F. A. C. S., Schumacher, U., Wedemann, G., & 2 Institute for Anatomy and Experimental Morphology, U. C. C. (2020) · Mathematical Biosciences and Engineering · doi:10.3934/mbe.2020325 · Cited by 9
In vitro assessment of stearyl triphenyl phosphonium toxicity in drug-resistant tumor cells
Shah, S., Ouellette, M., & D’Souza, G. G. M. (2022) · 4open · doi:10.1051/fopen/2022003 · Cited by 5 · cited 2×
“The conventional drug screening workflow typically begins with testing compounds on tumor cells cultured as 2D monolayers, followed by evaluation in animal models [163–165].”
Self-citationBenien, P., Almuteri, M., Shah, S., Böhlke, M., Mehanna, A., & D’Souza, G. G. M. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1262-0_7 · Cited by 4
Self-citationExtra cellular matrix a modular soil for stem cells
Irminger-Finger, I., Kargul, J., & Laurent, G. J. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.11.012 · Cited by 3 · cited 1×
“The extracellular matrix (ECM), a non-cellular component of the TME, is a highly dynamic and structurally complex scaffold that plays a critical role in regulating tumor progression and therapeutic response [72–74].”
Fibroblasts as Playmakers of Cancer Progression: Current Knowledge and Future Perspectives
Ishii, K. (2023) · Cancers · doi:10.3390/cancers15235538 · Cited by 1 · cited 1×
“This central accumulation of fibroblasts is consistent with known in vivo behavior, where stromal cells such as fibroblasts migrate toward hypoxic regions to participate in extracellular matrix remodeling and survival signaling [279–282].”
Cowan (2001) · doi:10.1002/1097-0215(20010101)91:1<120::aid-ijc1021>3.0.co;2-y
Research works printed but not linked: 1
- Shah S. Development of co-culture spheroid models of drug-resistant carcinomas for the in vitro testing of anti-tumor treatment strategies Doctor of Philosophy Dissertation MCPHS Boston, USA 2024
Cited by
Madan, A., Saini, R., Dhiman, N., Juan, S., & Satapathy, M. K. (2025) · Organoids · doi:10.3390/organoids4040023 · Cited by 24
“Organoids derived from CSC-enriched populations often demonstrate enhanced tumorigenicity, metastatic potential, and therapeutic resistance, making them ideal models for studying relapse, dormancy, and evolution under drug pressure [36].”
Cancer Metastasis: Therapeutic Challenges and Opportunities
Garemilla, S. S. S., Kadambala, M. C., Gampa, S. C., Chinthala, S., & Garimella, S. V. (2025) · Medical Oncology · doi:10.1007/s12032-025-03072-x · Cited by 15
“The bio-physical properties of the TME particularly its dense ECM and elevated interstitial fluid pressure limit uniform drug distribution and reduce therapeutic efficacy, often contributing to treatment failure and recurrence [98].”
Shukla, A. K., Shukla, S., Suryawanshi, S. P., Upadhyay, A. M., Ray, N., Thiruppathi, G., Dutta, S. D., & Mongre, R. K. (2025) · Current Oncology · doi:10.3390/curroncol32120653 · Cited by 10
“By integrating cellular, extracellular, and mechanical cues within a precisely engineered 3D matrix, these models overcome many limitations of conventional two-dimensional cultures, providing more physiologically relevant platforms for studying tumor biology [46,47].”
Mokhles, F., Moosavi, M. A., Gutiérrez-Uzquiza, Á., Velasco, G., Li, M., & Cordani, M. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218246 · Cited by 13
Stem Cell-Derived Organoids for Cancer Therapy: Precision Medicine and Drug Selection
Azim, M. M. N., Bhajan, S. K., Park, J. H., Abass, K. S., Rahman, A., Choi, M., Choi, J., Park, S., Kim, H. J., Akter, S., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27072954 · Cited by 8
Metadata
- Authors
- Shah, S., & D’Souza, G. G. M.
- Affiliations
- Massachusetts College of Pharmacy and Health Sciences (US)
- Corresponding author
- Shah, Shrey
- ORCID
- Shah, Shrey
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2025-05-17
- Volume
- 14
- Issue
- 10
- Pages
- 732
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC12110291
- OpenAlex
- W4410519085
- Cited by
- 83
- References
- 326
- Citations by year
- 2026: 72 · 2025: 11
- FWCI
- 9.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- tumor spheroids, tumor microenvironment, solid tumors, drug delivery barriers, extracellular matrix, hypoxia, interstitial fluid pressure, tumor-stroma interactions, 3D tumor models, drug penetration, drug resistance, confocal microscopy, cytotoxicity
- MeSH terms
- Animals, Humans, Models, Biological, Neoplasms, Spheroids, Cellular, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.